Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Abstract Parkinson’s disease (PD) is now considered to be a multisystemic disorder consequent on multineuropeptide dysfunction including dopaminergic, serotonergic, cholinergic, and noradrenergic systems. This multipeptide dysfunction leads to expression of a range of non-motor symptoms now known to...
Guardado en:
Autores principales: | MA Qamar, A Sauerbier, M Politis, H Carr, P Loehrer, K Ray Chaudhuri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c304aec45ee45608fd0713027d83a13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dopaminergic mechanisms of VNS-induced motor system plasticity
por: Catherine Thorn
Publicado: (2021) -
Neuroprotective Potential of Polydatin Against Motor Abnormalities and Dopaminergic Neuronal Loss in Rotenone Induced Parkinson Model
por: Ahmed,Muhammad Rashid, et al.
Publicado: (2018) -
TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: Xin He, et al.
Publicado: (2021) -
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi K, et al.
Publicado: (2016) -
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
por: Elke Warmerdam, et al.
Publicado: (2021)